Federal Judge Grants Summary Judgment in a Risperdal Lawsuit
Federal Judge Grants Summary Judgment in a Risperdal Lawsuit
Introduction
U.S. District Judge Denise J. Casper ruled in favor of Johnson & Johnson and its subsidiary Janssen Pharmaceuticals Inc. on Wednesday over claims by a Bay State man that the antipsychotic drug Risperdal caused him to gain excessive weight during his teenage years.
The lawsuit, filed by a man and his parents, lacked the backing of a medical expert to support their claim that Risperdal intake led to his unusual weight gain. Risperdal lawsuits filed across the U.S. accuse Johnson & Johnson and its affiliates of illegally marketing the product even after being aware of its gynecomastia risk. Individuals affected also claim the drug makers failed to warn that it is no more effective and comparatively less safe than other antipsychotic medications.
Over 7,000 Risperdal product liability lawsuits are filed in the Pennsylvania State Court against Janssen and its parent company J&J. Two coordinated actions have been filed for Risperdal cases: one in Los Angeles Superior Court (Risperdal and Invega Product Liability Cases, JCCP 4775) and the other in Philadelphia (In Re: Risperdal Litigation, March 2010 Term, Case No. 100300296).
Comments
Latest News
Attorneys Seek Reconsideration of Talc MDL Daubert Ruling
Categories: General
Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…
Philips resolves DreamStation suits for $1.1B
Categories: Settlements
Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…
FDA OKs Generic OTC Naloxone Spray Approved by FDA
Categories: FDA Related
The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.
…